I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
LAB Research International To Deploy Provantis 7 in three Countries
December 2005
Rapidly Growing CRO Switches to Provantis 7 with Over 300 Users at Sites in Canada, Hungary and Denmark
Instem Launches Next Phase of Customer Involvement Program for Provantis 8 Project
December 2005
Comprehensive Requirements Phase completed; Design & Implementation Phase Well Underway
Instem Announces Launch of Hosted Provantis Solution
November 2005
Leading Pre-Clinical Solution Now Enables Smaller Labs to Utilize Same Technology Employed by Major Players; From Any Location Over The Web
Sanofi-aventis to Implement Dispense Globally
October 2005
We are delighted to announce that sanofi-aventis has just signed an agreement with Instem to implement Provantis Dispense worldwide.
Galderma to Implement Provantis 7
April 2005
Instem announced today that Galderma has signed a Provantis 7 license agreement for its new state-of-the-art R&D facility in Sophia Antipolis, South East France.
Instem Announces Launch Plans for Provantis 7
February 2005
Instem today announced its plans to launch Provantis 7 at this year's Society of Toxicology (SOT) conference in New Orleans.
Instem is delighted to announce that sanofi pasteur Limited of Toronto, Canada has signed a license agreement for Instem's Toxicology Resource Planning solution (TRP).
Pierre Fabre S.A. Signs Provantis License Agreement
January 2005
Instem is delighted to announce that Pierre Fabre S.A. of France has signed a Provantis license agreement for its Pharmacology & Toxicology laboratory based in Tours, France.